CEO has clearly stated that he did not expect any serious competition (besides Gild) in a future. Now, we know that he was wrong, very wrong. This has yet to be proven one way or the other. Also, I think ABBVs strategy of going after higher discount population (medicaid etc) protects them pretty well from another entrant.